Numerous studies, case reports, and global usage of Ivermectin, a Food and Drug Administration (FDA)-approved antiparasitic drug, have shown that it is protective against infection and protective against severe disease. In this video, Pierre Kory, MD, of the Front Line Covid-19 Critical Care (FLCCC) Alliance discusses the data, the studies, and the likely mechanisms by which Ivermectin can both prevent and treat disease. He has presented this new information to the National Institutes of Health (NIH), and Dr. Kory’s soon-to-be-published manuscript and studies referenced can be found HERE. And more information and studies can be found c19vermectin.com.
